Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers

Table 2

Biomarkers of inflammation and lipid profile by gender and smoking status ( = 154).

	Males; = 71; mean ± SE	Females; = 83; mean ± SE	p value; (males versus females)
Serum C-reactive protein	7.4 ± 0.13	7.4 ± 0.11	0.66
Former smokers	7.2 ± 0.20	7.3 ± 0.16	0.58
Current smokers	7.6 ± 0.17	7.4 ± 0.16	0.27
value (former versus current)	0.10	0.87
Serum interleukin-6	0.67 ± 0.10	0.43 ± 0.10	0.09
Former smokers	0.44 ± 0.14	0.33 ± 0.13	0.57
Current smokers	0.86 ± 0.13	0.50 ± 0.14	0.08
value (former versus current)	0.04	0.40
Total cholesterol (mg/dL)	193.2 ± 5.1	206.2 ± 4.0	0.04
Former smokers	189.5 ± 6.7	204.6 ± 5.5	0.08
Current smokers	196.1 ± 7.6	207.3 ± 5.7	0.23
value (former versus current)	0.52	0.74
High density lipoproteins (mg/dL)	47.0 ± 1.5	61.5 ± 1.6	<0.001
Former smokers	47.1 ± 2.3	59.0 ± 2.7	0.002
Current smokers	47.0 ± 1.9	63.4 ± 1.9	<0.001
value (former versus current)	0.99	0.17
Low density lipoproteins (mg/dL)	114.0 ± 4.2	119.7 ± 3.6	0.30
Former smokers	111.8 ± 5.3	118.9 ± 4.6	0.32
Current smokers	116.8 ± 1.9	120.4 ± 5.3	0.67
value (former versus current)	0.99	0.83
Total triglycerides (mg/dL)	175.0 ± 18.5	139.5 ± 7.1	0.06
Former smokers	165.4 ± 18.6	142.5 ± 11.2	0.28
Current smokers	182.9 ± 30.3	137.3 ± 9.2	0.12
value (former versus current)	0.64	0.71

Log transformed data for C-reactive protein and interleukin-6.